Biolevate (Seed)
Funding Details
Awarder
Inbox
Date Award
November 25, 2024
Vertical
Biotech and Health
Funding Amount
$6,000,000
Company Info
Traction
The company was recently made Station F’s Future 40 list.
Founders
Joel Belafa, Nathan Chen, Anas Laaroussi, Antoine De Torcy
Market
Medical Writing
Location
Paris, France
Coinvestors
EQT Ventures
Company Description

Biolevate helps medical writers go faster with a platform that uses NLP and visual document reading to assist in writing documentation for new drugs.

Links